How I faced my prostate cancer: a molecular biologist’s perspective

Hippocrates (Kos, c.460–c.370 BC) reminds us that “It is more important to know what sort of person has a disease than to know what sort of disease a person has”. This is still true today and reflects the emerging role of personalized medicine for patient-specific risk stratification and treatment p...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Monica Zuradelli, Massimo Lazzeri, Egesta Lopci, Paolo Andrea Zucali, Luca Balzarini, Giorgio Guazzoni, Piergiuseppe Colombo, Marta Scorsetti, Ciro Franzese, Rosanna Asselta, Giulia Soldà, Stefano Duga
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2021
Materias:	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/519b98d194d943a496e128425d596a58
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:519b98d194d943a496e128425d596a58
record_format	dspace
spelling	oai:doaj.org-article:519b98d194d943a496e128425d596a582021-12-02T15:14:36ZHow I faced my prostate cancer: a molecular biologist’s perspective10.1038/s41698-021-00229-52397-768Xhttps://doaj.org/article/519b98d194d943a496e128425d596a582021-09-01T00:00:00Zhttps://doi.org/10.1038/s41698-021-00229-5https://doaj.org/toc/2397-768XHippocrates (Kos, c.460–c.370 BC) reminds us that “It is more important to know what sort of person has a disease than to know what sort of disease a person has”. This is still true today and reflects the emerging role of personalized medicine for patient-specific risk stratification and treatment programs. This report documents my personal experience as a patient with aggressive prostate cancer, who, as a scientist, had the privilege to access cutting-edge medical care and molecular profiling.Monica ZuradelliMassimo LazzeriEgesta LopciPaolo Andrea ZucaliLuca BalzariniGiorgio GuazzoniPiergiuseppe ColomboMarta ScorsettiCiro FranzeseRosanna AsseltaGiulia SoldàStefano DugaNature PortfolioarticleNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENnpj Precision Oncology, Vol 5, Iss 1, Pp 1-4 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
spellingShingle	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Monica Zuradelli Massimo Lazzeri Egesta Lopci Paolo Andrea Zucali Luca Balzarini Giorgio Guazzoni Piergiuseppe Colombo Marta Scorsetti Ciro Franzese Rosanna Asselta Giulia Soldà Stefano Duga How I faced my prostate cancer: a molecular biologist’s perspective
description	Hippocrates (Kos, c.460–c.370 BC) reminds us that “It is more important to know what sort of person has a disease than to know what sort of disease a person has”. This is still true today and reflects the emerging role of personalized medicine for patient-specific risk stratification and treatment programs. This report documents my personal experience as a patient with aggressive prostate cancer, who, as a scientist, had the privilege to access cutting-edge medical care and molecular profiling.
format	article
author	Monica Zuradelli Massimo Lazzeri Egesta Lopci Paolo Andrea Zucali Luca Balzarini Giorgio Guazzoni Piergiuseppe Colombo Marta Scorsetti Ciro Franzese Rosanna Asselta Giulia Soldà Stefano Duga
author_facet	Monica Zuradelli Massimo Lazzeri Egesta Lopci Paolo Andrea Zucali Luca Balzarini Giorgio Guazzoni Piergiuseppe Colombo Marta Scorsetti Ciro Franzese Rosanna Asselta Giulia Soldà Stefano Duga
author_sort	Monica Zuradelli
title	How I faced my prostate cancer: a molecular biologist’s perspective
title_short	How I faced my prostate cancer: a molecular biologist’s perspective
title_full	How I faced my prostate cancer: a molecular biologist’s perspective
title_fullStr	How I faced my prostate cancer: a molecular biologist’s perspective
title_full_unstemmed	How I faced my prostate cancer: a molecular biologist’s perspective
title_sort	how i faced my prostate cancer: a molecular biologist’s perspective
publisher	Nature Portfolio
publishDate	2021
url	https://doaj.org/article/519b98d194d943a496e128425d596a58
work_keys_str_mv	AT monicazuradelli howifacedmyprostatecanceramolecularbiologistsperspective AT massimolazzeri howifacedmyprostatecanceramolecularbiologistsperspective AT egestalopci howifacedmyprostatecanceramolecularbiologistsperspective AT paoloandreazucali howifacedmyprostatecanceramolecularbiologistsperspective AT lucabalzarini howifacedmyprostatecanceramolecularbiologistsperspective AT giorgioguazzoni howifacedmyprostatecanceramolecularbiologistsperspective AT piergiuseppecolombo howifacedmyprostatecanceramolecularbiologistsperspective AT martascorsetti howifacedmyprostatecanceramolecularbiologistsperspective AT cirofranzese howifacedmyprostatecanceramolecularbiologistsperspective AT rosannaasselta howifacedmyprostatecanceramolecularbiologistsperspective AT giuliasolda howifacedmyprostatecanceramolecularbiologistsperspective AT stefanoduga howifacedmyprostatecanceramolecularbiologistsperspective
_version_	1718387569058643968

How I faced my prostate cancer: a molecular biologist’s perspective

Ejemplares similares